Literature DB >> 12950156

R208X mutation in CLN2 gene associated with reduced cerebrospinal fluid pterins in a girl with classic late infantile neuronal ceroid lipofuscinosis.

Nina Barisić1, Peter Logan, Slaven Pikija, Drago Skarpa, Nenad Blau.   

Abstract

Clinical picture of neuronal ceroid lipofuscinosis with late infantile onset (LINCL) is characterized by myoclonic seizures and psychomotor regression. We present a case of classic LINCL and reduced cerebrospinal fluid (CSF) pterins in a girl of normal psychomotor development and born to non-consanguineous parents. She first presented with febrile seizures at the age of four. At that time, brain computed tomography finding was normal, but electroencephalogram showed hypsarrhythmia. At the age of five, tremor, generalized ataxia, and motor and mental regression appeared. Brain magnetic resonance imaging showed cerebellar atrophy. Electron microscopy examination showed storage of intracytoplasmic curvilinear inclusions in neurons, fibroblasts, and secretory cells of the skin and rectal mucosa. Tripeptidyl peptidase I (TPP-I) activity in leukocytes was very low (5.4 nmol/h/mg protein; range in homozygote cases of LINCL, 0.4-26.0). Molecular genetic studies showed a homozygous mutation, R208X, in exon 6 of CLN2 gene. CSF analysis revealed very low neopterin (7.3 nmol/L; normal range, 9-30) and biopterin (4.1 nmol/L; normal range, 10-30), reduced homovanillic acid (266 nmol/L; normal range, 211-871), and low homovanillic acid/5-hydroxyindoleacetic acid ratio (1.21; normal ratio, 1.5-3.5). Treatment with L-Dopa/Carbidopa (4 mg/kg) and antiepileptics was introduced, but without significant effect. It seems that low CSF pterins and impaired dopamine turnover are secondary manifestations of classical LINCL caused by homozygous inheritance of the R208X mutation in CLN2 gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12950156

Source DB:  PubMed          Journal:  Croat Med J        ISSN: 0353-9504            Impact factor:   1.351


  5 in total

Review 1.  Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.

Authors:  Sara E Mole; Ruth E Williams; Hans H Goebel
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

2.  Alterations in striatal dopamine catabolism precede loss of substantia nigra neurons in a mouse model of juvenile neuronal ceroid lipofuscinosis.

Authors:  Jill M Weimer; Jared W Benedict; Yasser M Elshatory; Douglas W Short; Denia Ramirez-Montealegre; Deborah A Ryan; Noreen A Alexander; Howard J Federoff; Jonathan D Cooper; David A Pearce
Journal:  Brain Res       Date:  2007-05-21       Impact factor: 3.252

3.  Batten disease: biochemical and molecular characterization revealing novel PPT1 and TPP1 gene mutations in Indian patients.

Authors:  Jayesh Sheth; Mehul Mistri; Riddhi Bhavsar; Dhairya Pancholi; Mahesh Kamate; Neerja Gupta; Madhulika Kabra; Sanjiv Mehta; Sheela Nampoothiri; Arpita Thakker; Vivek Jain; Raju Shah; Frenny Sheth
Journal:  BMC Neurol       Date:  2018-12-12       Impact factor: 2.903

Review 4.  Altered protein secretion in Batten disease.

Authors:  Robert J Huber
Journal:  Dis Model Mech       Date:  2021-12-06       Impact factor: 5.758

5.  Neuronal ceroid lipofuscinosis in the Russian population: Two novel mutations and the prevalence of heterozygous carriers.

Authors:  Anastasiya A Kozina; Elena G Okuneva; Natalia V Baryshnikova; Olga B Kondakova; Ekaterina A Nikolaeva; Inessa D Fedoniuk; Svetlana V Mikhailova; Anna Y Krasnenko; Ivan F Stetsenko; Nikolay A Plotnikov; Olesia I Klimchuk; Yaroslav V Popov; Ekaterina I Surkova; Peter A Shatalov; Alexander S Rakitko; Valery V Ilinsky
Journal:  Mol Genet Genomic Med       Date:  2020-05-15       Impact factor: 2.473

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.